We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$527B
AUM Growth
-$50.5B
Cap. Flow
-$9.14B
Cap. Flow %
-1.73%
Top 10 Hldgs %
31.73%
Holding
16,069
New
1,671
Increased
6,327
Reduced
6,228
Closed
1,710

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.44B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.15B
3
GEHC icon
GE HealthCare
GEHC
+$552M
4
DHR icon
Danaher
DHR
+$447M
5
MSTR icon
Strategy Inc
MSTR
+$416M

Sector Composition

Rank Sector Weight
1 Healthcare 3.24%
2 Technology 2.87%
3 Financials 2.43%
4 Consumer Discretionary 2.22%
5 Industrials 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NARI
15926
DELISTED
Inari Medical, Inc. Common Stock
NARI
-231,696
Closed -$11.8M
NARI
15927
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
-4,500
Closed -$230K
BLACR
15928
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
-24,383
Closed -$2.93K
FYLG
15929
DELISTED
Global X Financials Covered Call & Growth ETF
FYLG
-7,051
Closed -$200K
BYNOW
15930
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
-24,232
Closed -$848
ZUO
15931
CALL
DELISTED
Zuora, Inc.
ZUO
-9,200
Closed -$91.3K
ZUO
15932
DELISTED
Zuora, Inc.
ZUO
-105,153
Closed -$1.04M
ZUO
15933
PUT
DELISTED
Zuora, Inc.
ZUO
-13,900
Closed -$138K
SILV
15934
CALL
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-84,100
Closed -$765K
SILV
15935
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-799,078
Closed -$7.27M
SILV
15936
PUT
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-461,700
Closed -$4.2M
CTV
15937
DELISTED
Innovid Corp.
CTV
-152,819
Closed -$472K
RFACW
15938
DELISTED
RF Acquisition Corp. Warrants
RFACW
-10,602
Closed -$530
CTV.WS
15939
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
-10,155
Closed -$1.12K
ROIC
15940
CALL
DELISTED
Retail Opportunity Investments Corp.
ROIC
-3,900
Closed -$67.7K
ROIC
15941
DELISTED
Retail Opportunity Investments Corp.
ROIC
-102,400
Closed -$1.78M
ROIC
15942
PUT
DELISTED
Retail Opportunity Investments Corp.
ROIC
-1,600
Closed -$27.8K
EVGRW
15943
DELISTED
Evergreen Corporation Warrant
EVGRW
-42,825
Closed -$1.22K
SUM
15944
CALL
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-60,800
Closed -$3.08M
SUM
15945
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-51,174
Closed -$2.59M
SUM
15946
PUT
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-21,400
Closed -$1.08M
RVNC
15947
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
-281,200
Closed -$855K
RVNC
15948
DELISTED
Revance Therapeutics, Inc.
RVNC
-91,118
Closed -$277K
RVNC
15949
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
-407,800
Closed -$1.24M
SNAXW
15950
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
-47,733
Closed -$363

Similar funds

Citadel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Citadel Advisors held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,710 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.

By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
  • Citadel Advisors added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
  • Citadel Advisors's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
  • Citadel Advisors fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
  • Citadel Advisors's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
  • Citadel Advisors opened 1,671 new positions and closed 1,710 in Q1 2025.
  • Citadel Advisors's portfolio value fell 8.7% quarter-over-quarter to $527B.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.